Lumea and AIxMed team up to bring AI-driven urine cytology to Lumea's platform, targeting improved bladder cancer diagnostics. LEHI, UT, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Lumea, a leading...
Read More
Lehi, Utah — May 13, 2025 — Lumea, a leader in digital pathology and workflow innovation, is pleased to announce the upcoming transition of the Chief Executive Officer role, which...
Read More
LEHI, UT, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Lumea, a leader in digital pathology solutions. AIRA Matrix Private Limited, an innovative technology company for AI-based diagnostic, prognostic, and predictive...
Read More
Lumea’s Digital Diagnostic Suite™ (Viewer+™) Receives FDA 510(k) Clearance* for Clinical Diagnosis LEHI, UTAH, UNITED STATES, March 18, 2025 /EINPresswire.com/ – Lumea, a leader in digital pathology solutions, is proud…
Lumea and Myriad Genetics have partnered to integrate Myriad’s Prolaris® and MyRisk® molecular diagnostic tests into Lumea’s BxLink™ digital pathology platform. LEHI, UT, UNITED STATES, February 5, 2025 /EINPresswire.com/ --...
Read More
Lumea partners with Mindpeak to integrate AI tools like Breast Suite and Gleason grading into its platform, advancing precision in digital pathology. LEHI, UT, UNITED STATES, January 28, 2025 /EINPresswire.com/...
Read More
